FDA 483 - Mrinal M. Gounder, M.D. - March 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Mrinal M. Gounder, M.D., a clinical investigator in New York, NY, received a Form FDA 483 with two observations during an inspection from February 21 to March 3, 2023. The inspection revealed failures to conduct investigations in accordance with the investigational plan, specifically regarding the timely submission of deviation reports. Additionally, the firm failed to promptly report serious adverse events to the sponsor, indicating significant non-compliance with clinical trial regulations.
ID · 4882c910-4b0d-4522-bd77-dddbdac9516e